Hepatitis C liver disease during COVID-19 pandemic in Egypt: Challenges and way forward.

K S Abbas, M B S Kaml, M A F Metry, M Adwi, S A Aboelfath, M M Hasan, A Saha

Open access · bronzeAbstract read

In one paragraph

Article in Ethics, medicine, and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

0.5field-weighted citation impact, top 34% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve "gold tier" in conquering the disease.Proceedings (Baylor University. Medical Center) · 2024
Article
Marburg virus disease: the paradox of Nigeria's preparedness and priority effects in co-epidemics.Bulletin of the National Research Centre · 2023
Review
Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India.BMC public health · 2022
Article
A new infodemiological approach through Google Trends: longitudinal analysis of COVID-19 scientific and infodemic names in Italy.BMC medical research methodology · 2022
Article
Marburg virus disease outbreak amidst COVID-19 in the Republic of Guinea: A point of contention for the fragile health system?Clinical epidemiology and global health
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

K S AbbasFaculty of Medicine, Alexandria University, Alexandria, Egypt.

M B S KamlFaculty of Medicine, Ain Shams University, Cairo, Egypt.

M A F MetryFaculty of Medicine, Ain Shams University, Cairo, Egypt.

M AdwiFaculty of Medicine, Al-Azhar University, Cairo, Egypt.

S A AboelfathFaculty of Medicine, Alexandria University, Alexandria, Egypt.

M M HasanDepartment of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, 1902 Tangail, Bangladesh.

A SahaDepartment of Biotechnology, Heritage Institute of Technology, Kolkata, West Bengal, India.

Ain Shams University · EGAlexandria University · EGAl-Azhar University · EGMawlana Bhashani Science and Technology University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19EgyptHCVPandemic

Identifiers

PMID34778505

DOI10.1016/j.jemep.2021.100702

PMCPMC8575068

OpenAlexW3196650486

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.